Factors Facilitating and Hindering Development of a Medication Use Review Service in Eastern Europe and Iran-Cross-Sectional Exploratory Study
Authors:
- Anita TuulaATAnita Tuula
- Daisy VolmerDaisy Volmer
- Liisa JõhvikLJLiisa Jõhvik
- Ieva RutkovskaIRIeva Rutkovska
- Indre TrečiokienėITIndre Trečiokienė
- Piotr MerksPiotr Merks
- Magdalena Waszyk-NowaczykMagdalena Waszyk-Nowaczyk
- Mariola DrozdMariola Drozd
- Alena TatarevićATAlena Tatarević
- Maja RadovanlijaMRMaja Radovanlija
- Carmen PacadiCPCarmen Pacadi
- Arijana MeštrovićArijana Meštrović
Open Access
- 14 September 2021
- journal article
- review article
- Published by MDPI AG in Healthcare
- Vol. 9 (9) , 1207
Abstract
Polypharmacy is a common issue in patients with chronic diseases. Eastern-European countries and Iran are exploring possibilities for implementing the Medication Use Review (MUR) as a measure for optimizing medication use and ensuring medication safety in polypharmacy patients. The aim of this study was to gain insights into the development of the community pharmacy sector and map facilitators and barriers of MUR in Eastern Europe and Iran. The representatives of the framework countries received a questionnaire on community pharmacy sector indicators, current and future developments of pharmacies, and factors encouraging and hindering MUR. To answer the questionnaire, all representatives performed document analysis, literature review, and qualitative interviews with key stakeholders. The socio-ecological model was used for inductive thematic analysis of the identified factors. Current community pharmacist competencies in framework countries were more related to traditional pharmacy services. Main facilitators of MUR were increase in polypharmacy and pharmaceutical waste, and access to patients’ electronic list of medications by pharmacists. Main barriers included the service being unfamiliar, lack of funding and private consultation areas. Pharmacists in the framework countries are well-placed to provide MUR, however, the service needs more introduction and barriers mostly on organizational and public policy levels must be addressed.Keywords
This publication has 25 references indexed in Scilit:
- Medication review practices in European countriesResearch in Social and Administrative Pharmacy, 2014
- Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New ZealandInternational Journal of Clinical Pharmacy, 2014
- A systematic review and meta‐analysis of pharmacist‐led fee‐for‐services medication reviewBritish Journal of Clinical Pharmacology, 2013
- Medicines use reviews: a potential resource or lost opportunity for general practice?BMC Family Practice, 2013
- The contribution of the Medicines Use Review (MUR) consultation to counseling practice in community pharmaciesPatient Education and Counseling, 2011
- Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care SystemJournal of Managed Care Pharmacy, 2010
- Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: A multi-method studyHealth Policy, 2008
- Practice Change in Community Pharmacy: Quantification of FacilitatorsAnnals of Pharmacotherapy, 2008
- Polypharmacy in elderly patientsThe American Journal of Geriatric Pharmacotherapy, 2007
- Exploring elements of interprofessional collaboration between pharmacists and physicians in medication reviewPharmacy World & Science, 2007